Another initial clinical study found that the expression of hexokinase II mRNA was increased in tumor tissue in some HCC patients pretreated with TAE, and hexokinase II mRNA expression was significantly correlated with HIF-1α protein expression. This evidence concerns the gene HIF1A and hepatocellular carcinoma.